TPTE (transmembrane phosphatase with tensin homology) is a testis-specific tyrosine phosphatase with structural homology to the tumor suppressor PTEN 1. The protein contains at least two transmembrane domains and a tyrosine phosphatase motif, with multiple copies distributed across chr21 13, 15, 21, 22, and Y 12. TPTE is primarily expressed in secondary spermatocytes and prespermatids, suggesting a role in spermatogenesis 2. Mechanistically, TPTE exhibits phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity and protein tyrosine phosphatase activity, likely involved in signal transduction pathways 3. Functional analysis reveals that TPTE mutations affecting the catalytic P-loop result in variable effects on phosphatase activity, distinguishing it from PTEN's more severe loss-of-function patterns in tumors 3. In disease relevance, TPTE has emerged as a tumor-associated antigen in melanoma. Expression analysis demonstrates TPTE protein in 44.0% of pediatric melanomas and 48.3% of adult melanomas, supporting its potential as an immunotherapy target 4. The BNT111 mRNA vaccine, encoding TPTE among other melanoma antigens, is undergoing clinical testing 4. However, the biological function of TPTE remains incompletely understood compared to PTEN 1.